Strand Therapeutics

Strand Therapeutics has developed a drug candidate made of self-replicating mRNA that can make cancers more responsive to immunotherapy. Its synthetic mRNA programming technology makes its drug candidate safer than other gene therapies, more effective in patients, and cheaper to manufacture.